Traditionally, the activity of organochalcogen based redox catalysts in cancer cells has been associated with the increase of ROS levels. Using a phenotype guided approach we were able to identify tubulin and actin as targets of tellurium containing redox catalysts. This is the first detection of a defined intracellular target of such compounds.
MedChemComm
- Information Point